Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo

Postmenopausal Osteoporosis With Pathological Fracture Clinical Trial

Official title: Comparación de la Eficacia y Seguridad clínicas de Osteofortil Respecto de Forteo

Status Active, not recruiting

Clinical Trial Summary

The primary objective of this study is to compare efficacy and safety of two formulations of teriparatide 20 mcg/day plus calcium and vitamin D in postmenopausal women with osteoporosis.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Osteoporosis
• Osteoporosis, Postmenopausal
• Osteoporotic Fractures
• Postmenopausal Osteoporosis With Pathological Fracture

• NCT number: NCT01945788
• Study type: Interventional
• Source: Bio Sidus SA
• Status: Active, not recruiting
• Phase: Phase 4
• Start date: June 2013
• Completion date: November 2014